LeMaitre Vascular Inc (NASDAQ:LMAT)
| 55.50 BATS BZX Real-Time Price As of 9:54am ET |  +0.71 / +1.30%Today’s Change | 27.91 Today|||52-Week Range 64.50 | +37.04% Year-to-Date |
Latest LMAT News | Press Releases
| Is LeMaitre (LMAT) a Solid Growth Stock? 3 Reasons to Think " Yes " Jul 21 / Zacks.com - Paid Partner Content | LeMaitre Vascular (LMAT) to Report Q2 Results: Wall Street Expects Earnings Growth Jul 15 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 54.79 |
| Today’s open | 54.92 |
| Day’s range | 54.92 - 55.50 |
| Volume | 141 |
| Average volume (3 months) | 142,064 |
| Market cap | $1.2B |
Data as of 9:54am ET, 07/26/2021
Growth & Valuation
| Earnings growth (last year) | +15.79% |
| Earnings growth (this year) | +24.84% |
| Earnings growth (next 5 years) | +18.80% |
| Revenue growth (last year) | +10.35% |
| P/E ratio | 47.8 |
| Price/Sales | 6.41 |
| Price/Book | 6.51 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ATRIAtrion Corp | 0.00 | 0.00% |
| MDXGMiMedx Group Inc | +0.10 | +0.85% |
| CRYCryoLife Inc | +0.04 | +0.16% |
| ANGOAngioDynamics Inc | +0.01 | +0.04% |
Data as of 10:02am ET, 07/26/2021
Financials
| Next reporting date | July 30, 2021 |
| EPS forecast (this quarter) | $0.35 |
| Annual revenue (last year) | $129.4M |
| Annual profit (last year) | $21.2M |
| Net profit margin | 16.40% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Burlington, Massachusetts |
Forecasts
